Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
1,379
Price
$42.78
Total Value
$59,000.51
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Jun 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 22, 2026 |
| Shares Sold | 1,379 |
| Price per Share | $42.78 |
| Total Value | $59,000.51 |
| Shares Owned After | 55,639 |
| Derivative | No |
| Accession Number | 0001882764-26-000005 |
| Document | View SEC Filing |